WINDGAP MEDICAL

Since its inception, Windgap Medical has been revolutionizing drug delivery devices and the medicine they contain to create simple, safe, and stable solutions for today's most concerning health conditions. With 85+ issued patents, Windgap seeks to improve the lives of patients with life-threatening allergies, diabetes, opioid addiction, cyanide exposure, and more through its partnerships with ALK Abelló, University of Minnesota Twin Cities, National Institutes of Health, Allergy Partners, Molex, and more. Windgap Medical is based out of Watertown, Massachusetts, a growing pharmaceutical hub in the US... Windgap Medical, Inc. announced today that it has a strategic partnership with ALK-Abelló, A/S ("ALK") to commercialize the company's epinephrine autoinjector (EAI) for the treatment of anaphylactic shock... Founded in 2011, Windgap Medical has always been patient-first and technology-focused. What began as one conversation about life-threatening allergies and the inadequacies of..

Also known as: Windgap Medical, Inc.

Primary location: Watertown United States